We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
+9.25%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$3.27B
AUM Growth
-$46.7M
Cap. Flow
-$431M
Cap. Flow %
-13.18%
Top 10 Hldgs %
56.15%
Holding
134
New
19
Increased
35
Reduced
23
Closed
20

Top Buys

Rank Stock Value
1
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
+$44.1M
2
FCFS icon
FirstCash
FCFS
+$26.4M
3
SNDX icon
Syndax Pharmaceuticals
SNDX
+$20.4M
4
FTIVU
FinTech Acquisition Corp. IV Unit
FTIVU
+$20M
5
AKU
Akumin Inc
AKU
+$17.2M

Top Sells

Rank Stock Value
1
RH icon
RH
RH
+$39.3M
2
MED icon
Medifast
MED
+$37.9M
3
THC icon
Tenet Healthcare
THC
+$37.4M
4
HCA icon
HCA Healthcare
HCA
+$30.4M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$22.3M

Sector Composition

Rank Sector Weight
1 Healthcare 17.92%
2 Consumer Discretionary 6.06%
3 Industrials 4.77%
4 Technology 4.5%
5 Financials 3.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NATR icon
76
Nature's Sunshine
NATR
$280M
$6.91M 0.21%
597,310
– –
SIGA icon
77
SIGA Technologies
SIGA
$208M
$6.7M 0.21%
975,438
-200,000
-17% -$1.36M
HCA icon
78
HCA Healthcare
HCA
$89.1B
$6.42M 0.2%
51,448
-245,551
-83% -$30.4M
SSKN
79
DELISTED
Strata Skin Sciences
SSKN
$6.33M 0.19%
468,506
– –
RDI icon
80
Reading International Class A
RDI
$34.5M
$6.12M 0.19%
1,900,818
+336,184
+21% +$1.37M
XELA
81
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$5.84M 0.18%
1,265
-51
-4% -$286K
AFI
82
DELISTED
Armstrong Flooring, Inc.
AFI
$5.37M 0.16%
1,556,435
– –
UPBD icon
83
Upbound Group
UPBD
$1.12B
$5.29M 0.16%
177,165
+1,655
+0.9% +$48.9K
VG
84
CALL
DELISTED
Vonage Holdings Corporation
VG
$5.12M 0.16%
+500,000
New +$5.55M
ACET icon
85
Adicet Bio
ACET
$76.6M
$4.94M 0.15%
25,949
– –
ITCI
86
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$4.48M 0.14%
+174,461
New +$3.98M
STRM
87
DELISTED
Streamline Health Solutions
STRM
$4.3M 0.13%
183,573
– –
YTRA icon
88
Yatra Online
YTRA
$54.1M
$3.99M 0.12%
5,320,000
– –
SRL icon
89
Scully Royalty
SRL
$90.3M
$3.7M 0.11%
753,885
– –
APEN
90
DELISTED
Apollo Endosurgery, Inc.
APEN
$3.23M 0.1%
1,913,972
+65,300
+4% +$98.5K
DMAC icon
91
DiaMedica Therapeutics
DMAC
$380M
$3.21M 0.1%
756,193
+6,193
+0.8% +$32.8K
CALC icon
92
CalciMedica
CALC
$10.3M
$3.18M 0.1%
+17,857
New +$3.72M
MACK
93
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$3.01M 0.09%
751,943
+4,308
+0.6% +$15.8K
ACER
94
DELISTED
Acer Therapeutics Inc
ACER
$2.85M 0.09%
990,655
– –
DVD
95
DELISTED
Dover Motorsports
DVD
$2.67M 0.08%
1,895,541
+200,000
+12% +$288K
NEOS
96
DELISTED
Neos Therapeutics, Inc
NEOS
$2.44M 0.07%
4,610,000
– –
TNGX icon
97
Tango Therapeutics
TNGX
$4.28B
$2.07M 0.06%
+200,000
New +$2.04M
ONCT
98
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$2.04M 0.06%
+60,037
New +$2.94M
PRTY
99
DELISTED
Party City Holdco Inc.
PRTY
$2.03M 0.06%
+834,002
New +$1.76M
CYRN
100
DELISTED
CYREN Ltd.
CYRN
$1.99M 0.06%
91,963
+38,824
+73% +$952K
2 3
4
5 6

Similar funds

TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
NB
Nicolet Bankshares Green Bay, Wisconsin $2.71B AUM 17.55% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
BCM
Bowie Capital Management Richardson, Texas $2.71B AUM 5.42% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return

Nantahala Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Nantahala Capital Management held 134 positions worth $3.27B, down 1.4% from $3.32B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Nantahala Capital Management withdrew a net $431M in Q3 2020, closing 20 positions and reducing 23 holdings. Its most notable exit was RH, an estimated $39.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Nantahala Capital Management opened a new position in Bristol-Myers Squibb Company Contingent Value Rights worth $34.7M.

  • Nantahala Capital Management's largest Q3 2020 buy was Bristol-Myers Squibb Company Contingent Value Rights: 15,437,336 shares worth $34.7M.
  • Nantahala Capital Management added most to TravelCenters of America LLC in Q3 2020, an estimated $16.5M increase.
  • Nantahala Capital Management's biggest Q3 2020 reduction was Tenet Healthcare, cutting an estimated $37.4M.
  • Nantahala Capital Management fully exited RH in Q3 2020, selling an estimated $39.3M.
  • Nantahala Capital Management's ten largest holdings make up 56% of its $3.27B portfolio in Q3 2020.
  • Nantahala Capital Management opened 19 new positions and closed 20 in Q3 2020.
  • Nantahala Capital Management's portfolio value fell 1.4% quarter-over-quarter to $3.27B.

Based on Nantahala Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.